Patented drug products sales by therapy class Canada 2022

Patented drug products sales in Canada in 2022, by therapeutic class (in million Canadian dollars)

Drug products patented sales in Canada by therapeutic class 2022

Last update:

Feb 20, 2024

Author:

��ƽ�� Research Department

Region:

Canada

Survey time period:

From 01/01/2022 to 31/12/2022

This statistic displays the sales of patented drug products in Canada in 2022, sorted by therapeutic class. Antineoplastics and immunomodulating agents generated around 8.1 billion Canadian dollars of revenue.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Patented drug products sales in Canada in 2022, by therapeutic class (in million Canadian dollars)

Get in touch with us for additional information

��ƽ��